Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs
Background: Veterinary management of mitral valve regurgitation due to mxyomatous valve disease in dogs is limited to medical treatments, which only postpones the onset of congestive heart failure or alleviates clinical symptoms. Most surgical procedures to manage this condition in humans require ca...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2020.597879/full |
id |
doaj-a8dbeccf226f4318aa8635469c3387ae |
---|---|
record_format |
Article |
spelling |
doaj-a8dbeccf226f4318aa8635469c3387ae2020-12-17T07:35:05ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692020-12-01710.3389/fvets.2020.597879597879Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in DogsBo Liu0Stacey B. Leach1Wenzhi Pan2Fangyu Zheng3Liujun Jia4Xueying Zhou5Jing Li6College of Veterinary Medicine, China Agricultural University, Beijing, ChinaDepartment of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO, United StatesDepartment of Cardiology, Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Fudan University, Shanghai, ChinaCollege of Veterinary Medicine, China Agricultural University, Beijing, ChinaBeijing Key Laboratory of Pre-Clinic Research and Evaluation for Cardiovascular Implant Materials, Fuwai Hospital National Cardiovascular Centre, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, ChinaCollege of Veterinary Medicine, China Agricultural University, Beijing, ChinaCollege of Veterinary Medicine, China Agricultural University, Beijing, ChinaBackground: Veterinary management of mitral valve regurgitation due to mxyomatous valve disease in dogs is limited to medical treatments, which only postpones the onset of congestive heart failure or alleviates clinical symptoms. Most surgical procedures to manage this condition in humans require cardiopulmonary bypass and have a high risk of complications.Animals: Eight dogs with naturally occurring mitral valve regurgitation.Methods: Prospective observational study. All dogs were treated with a novel edge-to-edge transcatheter device named ValveClamp. The total surgical procedural time and total catheterization time were recorded. Echocardiographic variables measured pre- and post-procedure were compared using Wilcoxin-signed rank test with a P < 0.05 considered significant. Data were expressed as median and interquartile range and absolute numbers and percentages.Results: The procedural success rate was 100% and all the dogs survived without complications. The median (interquartile range) total surgical procedural time was 86.5 (76–96.2) minutes and catheterization time was 23.5 (22–33.8) minutes. Echocardiography revealed a significant reduction in mitral regurgitation severity in all dogs following the procedure based on both a reduced mitral regurgitant maximum jet area (P = 0.012) and a reduced mitral regurgitant maximum jet area to left atrial area (P = 0.018).Conclusion: The ValveClamp device is effective at reducing the severity of mitral regurgitation in dogs with naturally occurring myxomatous valve disease.https://www.frontiersin.org/articles/10.3389/fvets.2020.597879/fullcaninemitral valvemyxomatous degenerationtransapicalvalve surgery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bo Liu Stacey B. Leach Wenzhi Pan Fangyu Zheng Liujun Jia Xueying Zhou Jing Li |
spellingShingle |
Bo Liu Stacey B. Leach Wenzhi Pan Fangyu Zheng Liujun Jia Xueying Zhou Jing Li Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs Frontiers in Veterinary Science canine mitral valve myxomatous degeneration transapical valve surgery |
author_facet |
Bo Liu Stacey B. Leach Wenzhi Pan Fangyu Zheng Liujun Jia Xueying Zhou Jing Li |
author_sort |
Bo Liu |
title |
Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs |
title_short |
Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs |
title_full |
Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs |
title_fullStr |
Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs |
title_full_unstemmed |
Preliminary Outcome of a Novel Edge-to-Edge Closure Device to Manage Mitral Regurgitation in Dogs |
title_sort |
preliminary outcome of a novel edge-to-edge closure device to manage mitral regurgitation in dogs |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Veterinary Science |
issn |
2297-1769 |
publishDate |
2020-12-01 |
description |
Background: Veterinary management of mitral valve regurgitation due to mxyomatous valve disease in dogs is limited to medical treatments, which only postpones the onset of congestive heart failure or alleviates clinical symptoms. Most surgical procedures to manage this condition in humans require cardiopulmonary bypass and have a high risk of complications.Animals: Eight dogs with naturally occurring mitral valve regurgitation.Methods: Prospective observational study. All dogs were treated with a novel edge-to-edge transcatheter device named ValveClamp. The total surgical procedural time and total catheterization time were recorded. Echocardiographic variables measured pre- and post-procedure were compared using Wilcoxin-signed rank test with a P < 0.05 considered significant. Data were expressed as median and interquartile range and absolute numbers and percentages.Results: The procedural success rate was 100% and all the dogs survived without complications. The median (interquartile range) total surgical procedural time was 86.5 (76–96.2) minutes and catheterization time was 23.5 (22–33.8) minutes. Echocardiography revealed a significant reduction in mitral regurgitation severity in all dogs following the procedure based on both a reduced mitral regurgitant maximum jet area (P = 0.012) and a reduced mitral regurgitant maximum jet area to left atrial area (P = 0.018).Conclusion: The ValveClamp device is effective at reducing the severity of mitral regurgitation in dogs with naturally occurring myxomatous valve disease. |
topic |
canine mitral valve myxomatous degeneration transapical valve surgery |
url |
https://www.frontiersin.org/articles/10.3389/fvets.2020.597879/full |
work_keys_str_mv |
AT boliu preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs AT staceybleach preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs AT wenzhipan preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs AT fangyuzheng preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs AT liujunjia preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs AT xueyingzhou preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs AT jingli preliminaryoutcomeofanoveledgetoedgeclosuredevicetomanagemitralregurgitationindogs |
_version_ |
1724379988102217728 |